Yubo International Biotech Limited Stock

Equities

YBGJ

US9883661004

Biotechnology & Medical Research

Market Closed - OTC Markets 09:51:59 2024-04-12 am EDT 5-day change 1st Jan Change
0.95 USD -0.78% Intraday chart for Yubo International Biotech Limited 0.00% +216.67%
Sales 2022 0.1 Sales 2023 0.6 Capitalization 35.95M
Net income 2022 -1M Net income 2023 -1M EV / Sales 2022 116,560,264 x
Net Debt 2022 772K Net Debt 2023 386K EV / Sales 2023 60,084,725 x
P/E ratio 2022
-9.36 x
P/E ratio 2023
-30.1 x
Employees 18
Yield 2022 *
-
Yield 2023
-
Free-Float 6.63%
More Fundamentals * Assessed data
Dynamic Chart
Yubo International Biotech Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Yubo International Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Yubo International Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Yubo International Biotech Limited Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Yubo International Biotech Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Yubo International Biotech Limited Auditor Raises 'Going Concern' Doubt CI
Yubo International Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Insider Sell: Yubo International Biotech MT
Yubo International Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Yubo International Biotech Limited Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Yubo International Biotech Limited Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Yubo International Biotech Limited Auditor Raises 'Going Concern' Doubt CI
Yubo International Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Yubo International Biotech Limited Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Yubo International Biotech Limited Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
More news
1 day-0.78%
Current month-4.04%
3 months+216.67%
6 months+214.57%
Current year+216.67%
More quotes
1 month
0.57
Extreme 0.567
1.03
Current year
0.11
Extreme 0.11
1.04
1 year
0.07
Extreme 0.0651
1.04
3 years
0.00
Extreme 0
1.30
5 years
0.00
Extreme 0
3.98
10 years
0.00
Extreme 0
3.98
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 18-12-31
Director of Finance/CFO 45 18-12-31
Director/Board Member 45 18-12-31
Members of the board TitleAgeSince
Director/Board Member 45 18-12-31
Director of Finance/CFO 45 18-12-31
Director/Board Member 39 19-12-31
More insiders
Date Price Change Volume

Delayed Quote OTC Markets, April 12, 2024 at 09:51 am EDT

More quotes
Yubo International Biotech Ltd, formerly Magna-Lab Inc, is a holding company primarily operating through its subsidiary. The Company focuses on the research and development and application of endometrial stem cells and offers its products and services under the brand VIVCELL. The Company’s product offerings include healthcare products for respiratory system, skincare products, hair care products, healthy beverages and male and female personal care products. The Company also offers stem cell related services including cell testing and health management consulting services.
More about the company